Feature | Specification |
---|---|
Unit Size | 1 vial (10 doses) |
Specificity | Cathepsin B |
IVISense Cat B 680 FAST™ is a Cathepsin B activatable fluorescent probe that is optically silent upon injection and produces fluorescent signal after cleavage by Cathepsin B produced by inflammatory cells and tumor cells. IVISense Cat B 680 FAST may be used to monitor inflammation, tumor activity, progression of disease and the efficacy of therapeutic treatment in applications such as oncology, inflammation, cardiovascular disease and some neurological diseases.
IVISense Cat B 680 FAST is a member of a family of activatable fluorescent imaging agents comprising a novel architecture, termed F.A.S.T. (Fluorescent Activatable Sensor Technology) that confers an improved pharmacokinetic profile with a broader range of early imaging time points. This architecture also offers higher target-specific signal with reduced background.
Brand |
IVISense
|
---|---|
Fluorescent Agent Type |
Enzyme activated
|
Imaging Modality |
Fluorescence
|
Shipping Conditions |
Shipped Ambient
|
Specificity |
Cathepsin B
|
Storage Conditions |
+2 to +8 °C
|
Therapeutic Area |
Arthritis
Atherosclerosis
Cardiovascular
Inflammation
Oncology
Pulmonary
Vascular
|
Unit Size |
1 vial (10 doses)
|
Wave Length |
680 nm
|
Are you looking for resources, click on the resource type to explore further.
Non-alcoholic fatty liver disease (NAFLD) describes a progressive pathology that affects the liver. Fat accumulation causes fatty...
Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into...
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and...
We are here to answer your questions.